TruTag named Technology Pioneer by World Economic Forum
HONOLULU — A company that has developed an edible security platform for addressing the global problem of counterfeit foods and medicines has been named a 2014 Technology Pioneer by the World Economic Forum.
TruTag Technologies, based in Honolulu, said the award is given to companies that design, develop and deploy new technologies holding promise or significantly affecting the way business and society operates. TruTag was one of 36 companies around the world to receive the distinction from the World Economic Forum, which will have its annual "Summer Davos" Meeting of the New Champions 2013 in Dalian, China, next month. Past winners have included Twitter and Google.
"With their ability to profoundly affect the world’s current counterfeit crisis, TruTag Technologies is a great fit for the Technology Pioneer awards," Stanford University entrepreneurship professor and past Technology Pioneer awards judge Tom Byers said. "Technology Pioneer candidates are evaluated by the world’s leading technology experts in a rigorous selection process. This selection distinguishes TruTag Technologies as a global innovator and disruptor."
The meeting is considered the foremast global business gathering in Asia, attracting heads of state, heads of multinational corporations and CEOs of fast-growing companies.
"It is a great honor for TruTag to be selected as a Technology Pioneer by the World Economic Forum," TruTag chairman Hank C.K. Wuh said. "I am looking forward to discussing the role of innovation for the future of society and sharing our vision for TruTag to impact the global counterfeit problem, especially in the area of safety and authenticity of food and medicine where the impact of counterfeits on human lives is beyond measure."
Boots’ No7 introduces Lift & Luminate Day & Night Serum
NEW YORK — Building on the international success of the Protect & Perfect and Protect & Perfect Intense Serums, No7 from Boots has introduced Lift & Luminate Day & Night Serum.
The two-step system targets the three main signs of aging — uneven skin tone, the appearance of lines and wrinkles and loss of skin firmness — and according to the company, is clinically proven to diminish the appearance of age spots. It will appear in stores in September.
The serums include new scientific discoveries in skin lightening identified by Dr. Mike Bell, scientific skin care adviser for Boots, and his team. The discovery was then published in Experimental Dermatology. The formula reduces the appearance of lines and wrinkles and leaves skin feeling firmer, visibly lifted and with a more even skin tone.
In an eight-week user trial in November 2012, the feedback from 76 respondents after four weeks was:
- 90% noted their general pigmentation was less noticeable;
- 84% said lines and wrinkles were less visible in four weeks;
- 90% said their skin texture looked improved;
- 82% noticed their skin feels firmer; and
- 82% said their skin was younger-looking.
In addition, in only eight weeks, women said their age spots appeared faded by up to 50% of their original shade.
Priced at $24.99, Lift & Luminate Day & Night Serum will be available in the United States on Sept. 1 at Target stores nationwide, on Target.com, us.boots.com, Walgreens.com and select Walgreens locations. The serum has earned the Good Housekeeping Seal and is part of the complete Lift & Luminate skin care range, which includes day, night and eye creams, as well as foundations.
Report forecasts strong growth in global pharmaceutical packaging market
NEW YORK — The global market for drug packaging is expected to experience tremendous growth over the next few years, according to a new report.
The report, published by Transparency Market Research, found that it would grow from 2011’s $50.07 billion to $73.04 billion by 2018, with North America and Europe accounting for 60% of demand. The report looked at plastic bottles, parental containers, blister packs, closures, labels and others. Companies that manufacture pharmaceutical packaging include Amcor, Gerresheimer, BD, MeadWestvaco, Rexam, West Pharmaceutical Services, 3M and Tear and Tape, among others.
Plastic bottles were the largest product segment, accounting for more than 20% of the market in 2011, but parental containers are expected to grow fastest due to the introduction of new injected therapies on account of advancements in biotechnology.